Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches
Chemotherapy is the main treatment for most early-stage cancers; nevertheless, its efficacy is usually limited by drug resistance, toxicity, and tumor heterogeneity. Cell-penetrating peptides (CPPs) are small peptide sequences that can be used to increase the delivery rate of chemotherapeutic drugs...
Main Authors: | Nuno Vale, Mariana Pereira, Joana Santos, Catarina Moura, Lara Marques, Diana Duarte |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/1/69 |
Similar Items
-
New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
by: Diana Duarte, et al.
Published: (2020-12-01) -
In-Silico Identification of Novel Pharmacological Synergisms: The Trabectedin Case
by: Laura Mannarino, et al.
Published: (2024-02-01) -
Drug synergism and dose-effect data analysis /
by: 226834 Tallarida, Ronald J.
Published: (2000) -
Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs
by: Diana Duarte, et al.
Published: (2021-07-01) -
Novel Strategies for Cancer Combat: Drug Combination Using Repurposed Drugs Induces Synergistic Growth Inhibition of MCF-7 Breast and HT-29 Colon Cancer Cells
by: Diana Duarte, et al.
Published: (2022-10-01)